IM Cannabis Archives

StaffNovember 13, 2023

The Daily Hit is a recap of the top financial news stories for Nov. 13, 2023. On the Site New York Judge Says Marijuana Regulators Erred in Hemp Enforcement A New York state judge delivered a setback to state marijuana regulators over an emergency hemp rule enacted over the summer. Justice Thomas Marcelle found that […]

Adam JacksonNovember 13, 2023

The restructuring initiatives cut total operating costs by 34%.

Debra BorchardtAugust 14, 2023

IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced its financial results today for the second quarter ending June 30, 2023. All amounts are reported in Canadian dollars. Revenues at IM Cannabis increased 4% for the second quarter to $13.2 million versus last year’s $12.7 million for the same time period. The net losses were flat […]

Adam JacksonMay 15, 2023

Restructuring initiatives included cutting its workforce in Israel by 21% across all functions.

Debra BorchardtMarch 29, 2023

IM Cannabis continued to refocus on Israel, Germany, and elsewhere in Europe.

Adam JacksonAugust 19, 2022

Economic headwinds in the industry are causing cannabis companies to make changes to their financing strategies. The news comes as cannabis capital raises are down 63.1% so far this year despite M&A movement soaring, according to a report by Viridian Capital Advisors. The cash crunch illustrates the rising stakes for those vying to survive in […]

Debra BorchardtAugust 15, 2022

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) reported financial results for its second quarter ended June 30, 2022. IMCC said that revenues rose 114% in the second quarter and were $23.8 million versus the same quarter last year. Total dried flower sold was 3,210 kilograms at an average selling price of $5.72 per gram, compared to 1,842 kilograms […]

StaffMarch 31, 2022

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) released financial results for the fourth quarter and fiscal year ended December 31, 2021. Revenues were $20.0 million in the fourth quarter, representing an increase of 309% over 2020’s fourth quarter and 35% sequentially. The net loss for the fourth quarter was $12.5 million versus a net loss of $20.0 […]

StaffMarch 10, 2022

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) provided preliminary unaudited financial results for the three months and fiscal year ended December 31, 2021. Preliminary revenues for the fourth quarter were at least $20 million, representing an approximate increase of at least 37% sequentially and at least 308% compared to the same prior-year period. Preliminary revenues for fiscal […]

StaffJuly 28, 2021

IM Cannabis Corp. (NASDAQ: IMCC) is buying R.A. Yarok Pharm Ltd. also called Pharm Yarok, Rosen High Way Ltd., and High Way Shinua. Ltd. by IMC Holdings Ltd., a wholly-owned Israeli subsidiary. The deal is valued at C$4.6 million. The acquisition is expected to integrate assets that include a license to sell medical cannabis to […]

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

In other news

The Daily Hit: January 4, 2024

Connecticut Attorney General Tells Unlicensed Cannabis Events Company to Stop

Testing Concerns Lead to Quarantine for 70% of Mississippi MMJ Goods

Tag: IM Cannabis

The Daily Hit: November 13, 2023

IM Cannabis Sales Slip Despite Improved Margins in Q3

IM Cannabis’ Revenues Inch Up

Restructuring, Strategy Rework Fuel IM Cannabis’ Q1 Profit Boost

IM Cannabis Sales Improve as it Leaves Canada

Headwinds Cause Cannabis Companies To Adapt Finances

IM Cannabis Revenues Rise As Company Burns Through Cash

IM Cannabis Reported $54 Million In Revenues for 2021

IM Cannabis Reports Rising Revenue

IM Cannabis Buys Two Israeli Companies

The Daily Hit - TEST TEST TEST

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

Get the latest cannabis news delivered right to your inbox